Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0E2XP
|
|||
Former ID |
DNC007894
|
|||
Drug Name |
N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]linoleamide
|
|||
Synonyms |
CHEMBL236385; BDBM22991; N-arachidonoylserotonin analogue, 1d
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C28H42N2O2
|
|||
Canonical SMILES |
CCCCCC=CCC=CCCCCCCCC(=O)NCCC1=CNC2=C1C=C(C=C2)O
|
|||
InChI |
1S/C28H42N2O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-28(32)29-21-20-24-23-30-27-19-18-25(31)22-26(24)27/h6-7,9-10,18-19,22-23,30-31H,2-5,8,11-17,20-21H2,1H3,(H,29,32)/b7-6-,10-9-
|
|||
InChIKey |
YJVMJUDLMFBYFZ-HZJYTTRNSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Transient receptor potential cation channel V1 (TRPV1) | Target Info | Inhibitor | [1] |
KEGG Pathway | Neuroactive ligand-receptor interaction | |||
Inflammatory mediator regulation of TRP channels | ||||
NetPath Pathway | IL2 Signaling Pathway | |||
Pathway Interaction Database | Trk receptor signaling mediated by the MAPK pathway | |||
Trk receptor signaling mediated by PI3K and PLC-gamma | ||||
Reactome | TRP channels |
References | Top | |||
---|---|---|---|---|
REF 1 | New N-arachidonoylserotonin analogues with potential "dual" mechanism of action against pain. J Med Chem. 2007 Dec 27;50(26):6554-69. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.